Wockhardt’s Zaynich gives new hope to cancer patient with successful liver transplant
Wockhardt's Zaynich antibiotic enables successful liver transplant for US cancer patient, shares soar, Phase III study nears ...
Why this pharma stock hit nearly 9-year high; froze at 10% upper circuit?
Wockhardt stock gained 10% to touch Rs 1,536.40; it has outperformed the market by zooming 262% thus far in calendar year ...